Efficacy of electroacupuncture in the treatment of peripheral neuropathy caused by Utidelone: Study protocol for a randomized controlled trial

Efficacy of electroacupuncture in the treatment of peripheral neuropathy caused by Utidelone: Study protocol for a randomized controlled trial

IntroductionUtidelone (UTD1) is a new chemotherapeutic drug for recurrent or metastatic breast cancer. However, it usually leads to severe peripheral neuropathy (PN) and causes numbness of the hands and feet and significant pain in patients' life. Electroacupuncture (EA) is considered beneficia...

Full description

Bibliographic Details
Main Authors: Chao Lu, Guangliang Li, Dehou Deng, Rongrong Li, Xiaoyu Li, Xukang Feng, Taoping Wu, Xiying Shao, Weiji Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-02-01
Series:Frontiers in Neurology
Subjects:
breast cancer
electroacupuncture (EA)
Utidelone (UTD1)
chemotherapy-induced peripheral neuropathy (CIPN)
peripheral neuropathy (PN)
protocol
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2023.1065635/full

Internet

https://www.frontiersin.org/articles/10.3389/fneur.2023.1065635/full

Similar Items